AI Summary
Generated by AI for informational purposes only
এটি একটি ইনজেকশন যা আরএইচ-নেগেটিভ গর্ভবতী নারীদের দেওয়া হয়। এটি মায়ের শরীরে এমন অ্যান্টিবডি তৈরি হওয়া থেকে বিরত রাখে যা শিশুর ক্ষতি করতে পারে। এটি বিশেষভাবে গর্ভাবস্থায় ব্যবহারের জন্য তৈরি এবং নিরাপদ বলে বিবেচিত।
Indications
Pregnancy and Other Obstetrical Conditions in Rh-Negative Women, Unless the Father or Baby are Conclusively Rh Negative:
Pregnancy/delivery of an Rh-positive baby irrespective of the ABO groups of the mother and baby
Abortion/threatened abortion at any stage of gestation
Ectopic pregnancy
... Read more
Pregnancy and Other Obstetrical Conditions in Rh-Negative Women, Unless the Father or Baby are Conclusively Rh Negative:
Pregnancy/delivery of an Rh-positive baby irrespective of the ABO groups of the mother and baby
Abortion/threatened abortion at any stage of gestation
Ectopic pregnancy
Antepartum fetal-maternal hemorrhage (suspected or proven) resulting from antepartum hemorrhage (e.g., placenta previa), amniocentesis, chorionic villussampling, percutaneous umbilical blood sampling, other obstetrical manipulative procedure (e.g., version) or abdominal trauma
Transfusion of Rh incompatible blood or blood products
Transfusion: Prevention of Rh immunization in any Rh-negative person after incompatible transfusion of Rh-positive blood or blood products (e.g., red blood cells, plateletconcentrates, granulocyte concentrates)
Pharmacology
Anti-D immunoglobulin prevents a rhesus-negative mother from actively forming antibodies to foetal rhesus-positive RBCs that may pass into the maternal circulation during childbirth, abortion, or certain other sensitising events. It is also used in idiopathic thrombocytopenic purpura to prevent excessive bleeding.
Dosage & Administration
Important: Do not take any medication without a doctor's prescription. Self-medication can be dangerous.
One dose 250 mcg should be given IM immediately or as soon as possible after delivery, or abortion of a Rh-positive child, preferably within 48 hours, but not later than 72 hours post-partum.
Following any potentially sensitizing episode (e.g stillbirth, amniocentesis) up to 20 weeks of gestation 125 mcg per episode (after 20 weeks of gestation, 250 mcg) immediately or within 72 hours.
For antenatal prophylaxis 250 mcg should be given in week 28 & also week 34 of pregnancy. The injection must only be given deep intramuscularly. Do not inject intravenously.
Interaction
Live vaccines should only be admin at least 3 mth after the last dose of immunoglobulin admin.
Contraindications
Splenectomised or rhesus-negative patients, in whom the resultant haemolysis may exacerbate pre-existing anaemia. Hypersensitivity.
Side Effects
Hypersensitivity reactions such as hives, wheezing, urticaria, Pain and tenderness at inj site. Fever, chills, nausea, facial flushing, headache.
Pregnancy & Lactation
Pregnancy Category C. Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.
Precautions & Warnings
For postpartum usage, it is to be used only for maternal admin. Not for rhesus-positive individuals. Patients should be observed for 20 minutes after admin.
Storage Conditions
Should be stored in cool and dry place.
The information provided on this page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Always consult a qualified healthcare professional before starting, stopping, or changing any medication.
All brands listed might have copyright or trademark of their respective owners. Listed information may not be up-to-date or accurate. We do not guarantee the availability, quality, price or safety of any medication. Use at your own risk.
